PFA Pension Forsikringsaktieselskab Buys New Position in Teleflex Incorporated $TFX

Key Points

• PFA Pension Forsikringsaktieselskab purchased a new position of 37,388 shares in Teleflex (NYSE:TFX), valued at about $4.55 million0.08% ownership.
• Teleflex reported a weak quarter with EPS $1.93 versus $3.73 expected and revenue of $569M versus $912.6M expected (revenue down 28.5% year‑over‑year), and set FY2026 guidance of 6.25–6.55 EPS.
• Street sentiment is mixed but cautious: the consensus rating is Hold (2 Buy, 6 Hold, 1 Sell) with an average price target of $133.57, and institutional investors own about 95.62% of the shares.

PFA Pension Forsikringsaktieselskab purchased a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 37,388 shares of the medical technology company's stock, valued at approximately $4,547,000. PFA Pension Forsikringsaktieselskab owned about 0.08% of Teleflex as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of TFX. MassMutual Private Wealth & Trust FSB increased its position in shares of Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company's stock valued at $26,000 after acquiring an additional 77 shares during the last quarter. Hantz Financial Services Inc. increased its position in shares of Teleflex by 248.8% in the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company's stock valued at $34,000 after acquiring an additional 199 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Teleflex in the third quarter valued at about $35,000. V Square Quantitative Management LLC acquired a new stake in shares of Teleflex in the fourth quarter valued at about $37,000. Finally, Quent Capital LLC acquired a new stake in shares of Teleflex in the third quarter valued at about $38,000. Institutional investors and hedge funds own 95.62% of the company's stock.

Wall Street Analyst Weigh In

TFX has been the topic of a number of recent research reports. Zacks Research raised Teleflex from a "strong sell" rating to a "hold" rating in a research report on Tuesday, April 28th. Royal Bank Of Canada reaffirmed a "sector perform" rating on shares of Teleflex in a research report on Tuesday, April 14th. Wall Street Zen raised Teleflex from a "sell" rating to a "hold" rating in a research report on Saturday, April 25th. Bank of America raised Teleflex from an "underperform" rating to a "neutral" rating and set a $135.00 target price on the stock in a research report on Monday, April 13th. Finally, Needham & Company LLC lifted their target price on Teleflex from $138.00 to $147.00 and gave the company a "buy" rating in a research report on Thursday, February 26th. Two research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $133.57.

Teleflex Trading Down 1.4%

Shares of NYSE:TFX opened at $120.02 on Tuesday. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $139.67. The stock has a market cap of $5.31 billion, a PE ratio of -5.84, a P/E/G ratio of 0.88 and a beta of 0.82. The business has a 50 day moving average of $118.74 and a 200-day moving average of $116.72. The company has a quick ratio of 2.01, a current ratio of 2.54 and a debt-to-equity ratio of 0.81.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, February 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.73 by ($1.80). Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The firm had revenue of $569.00 million for the quarter, compared to the consensus estimate of $912.57 million. During the same quarter in the prior year, the firm earned $3.89 EPS. The company's revenue was down 28.5% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts forecast that Teleflex Incorporated will post 6.77 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Friday, March 6th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. The ex-dividend date was Friday, March 6th. Teleflex's payout ratio is -6.62%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.